Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2008
DOI: 10.1002/9780470623992.ch40
|View full text |Cite
|
Sign up to set email alerts
|

Chapter 40. Nutrition and Osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2011
2011
2013
2013

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…The essentiality of these nutrients for bone integrity can be fully appreciated by the severe consequences observed following their selective/individual dietary deficiency. Thus, a limitation in Ca, Pi, or protein while the intakes of the other two nutrients are maintained at normal levels leads to severe bone structural deficiency associated with loss of bone strength, as observed in diseases such as osteoporosis or osteomalacia [ 10 , 11 ]. In order to play their structural role in bone, these three nutrients require a normal vitamin D status (see Interactions section for the interplay between Ca, Pi, protein, and vitamin D in bone metabolism).…”
Section: Bone and Skeletal Muscle Healthmentioning
confidence: 99%
“…The essentiality of these nutrients for bone integrity can be fully appreciated by the severe consequences observed following their selective/individual dietary deficiency. Thus, a limitation in Ca, Pi, or protein while the intakes of the other two nutrients are maintained at normal levels leads to severe bone structural deficiency associated with loss of bone strength, as observed in diseases such as osteoporosis or osteomalacia [ 10 , 11 ]. In order to play their structural role in bone, these three nutrients require a normal vitamin D status (see Interactions section for the interplay between Ca, Pi, protein, and vitamin D in bone metabolism).…”
Section: Bone and Skeletal Muscle Healthmentioning
confidence: 99%
“…In a large randomized, placebo-controlled trial, ipriflavone, another soy isoflavone did not prevent bone loss nor affected biochemical markers of bone remodelling in Western Caucasian postmenopausal women. Moreover, lymphocytopenia was observed in a significant number of women [ 53 ]. However, several epidemiological studies and clinical trials suggest that some soy isoflavones have beneficial effects on bone turnover markers and bone mechanical strength in postmenopausal women [ 54 ].…”
Section: Nutrition and Osteoporosismentioning
confidence: 99%
“…However, it is possible that the optimal health of the skeleton requires a good equilibrium between all nutrients. As already mentioned above, it is probable that mononutrient supplementation, as frequently recommended in several diets will not necessarily lead to an adequate bone quality [ 53 ].…”
Section: Nutrition and Osteoporosismentioning
confidence: 99%